BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33952289)

  • 1. Molecular-genetic characterization of human parvovirus B19 prevalent in Kerala State, India.
    Seetha D; Pillai HR; Nori SRC; Kalpathodi SG; Thulasi VP; Nair RR
    Virol J; 2021 May; 18(1):96. PubMed ID: 33952289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
    Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
    J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
    Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
    J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
    Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
    Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
    Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
    Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.
    Vadivel K; Mageshbabu R; Sankar S; Jain A; Perumal V; Srikanth P; Ranjan GA; Nair A; Simoes EAF; Nandagopal B; Sridharan G
    Indian J Med Res; 2018 Apr; 147(4):391-399. PubMed ID: 29998875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Genomic Characterization of Parvovirus B19V Genotype 3 Viruses from Cases of Meningoencephalitis in West Bengal, India.
    Pattabiraman C; Prasad P; Sudarshan S; George AK; Sreenivas D; Rasheed R; Ghosh A; Pal A; Hameed SKS; Bandyopadhyay B; Desai A; Vasanthapuram R
    Microbiol Spectr; 2022 Apr; 10(2):e0225121. PubMed ID: 35412386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of primate erythroparvovirus 1 between 2009 and 2016: First report from Turkey.
    Aydin H; Timurkan MO; Aktas O
    Microb Pathog; 2019 Apr; 129():131-135. PubMed ID: 30742946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
    Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
    J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
    Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic study of human parvovirus B19 infection in East China.
    Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
    J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
    Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
    J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
    Maple PA; Hedman L; Dhanilall P; Kantola K; Nurmi V; Söderlund-Venermo M; Brown KE; Hedman K
    J Clin Microbiol; 2014 Mar; 52(3):947-56. PubMed ID: 24403307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
    Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and progression of Parvovirus B19 infection and molecular changes in circulating B19V strains in children with haematological malignancy: A follow up study.
    Jain A; Jain P; Kumar A; Prakash S; Khan DN; Kant R
    Infect Genet Evol; 2018 Jan; 57():177-184. PubMed ID: 29170063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
    Molenaar-de Backer MW; Russcher A; Kroes AC; Koppelman MH; Lanfermeijer M; Zaaijer HL
    J Clin Virol; 2016 Nov; 84():19-23. PubMed ID: 27664778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
    Escher F; Kuhl U; Sabi T; Suckau L; Lassner D; Poller W; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Jun; 14(6):CR333-338. PubMed ID: 18509278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.